Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 8, no: 1 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: A0A3S7WY17
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 203 | 207 | PF00656 | 0.346 |
CLV_PCSK_KEX2_1 | 306 | 308 | PF00082 | 0.465 |
CLV_PCSK_PC1ET2_1 | 306 | 308 | PF00082 | 0.417 |
CLV_PCSK_PC7_1 | 302 | 308 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 223 | 227 | PF00082 | 0.536 |
CLV_PCSK_SKI1_1 | 307 | 311 | PF00082 | 0.439 |
DOC_CYCLIN_RxL_1 | 154 | 165 | PF00134 | 0.358 |
DOC_CYCLIN_yCln2_LP_2 | 146 | 149 | PF00134 | 0.416 |
DOC_MAPK_gen_1 | 275 | 283 | PF00069 | 0.300 |
DOC_MAPK_gen_1 | 314 | 322 | PF00069 | 0.660 |
DOC_MAPK_MEF2A_6 | 276 | 285 | PF00069 | 0.257 |
DOC_PP2B_LxvP_1 | 146 | 149 | PF13499 | 0.416 |
DOC_USP7_MATH_1 | 166 | 170 | PF00917 | 0.426 |
DOC_USP7_MATH_1 | 173 | 177 | PF00917 | 0.340 |
DOC_USP7_UBL2_3 | 102 | 106 | PF12436 | 0.309 |
DOC_USP7_UBL2_3 | 306 | 310 | PF12436 | 0.676 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.421 |
DOC_WW_Pin1_4 | 358 | 363 | PF00397 | 0.734 |
DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.453 |
LIG_14-3-3_CanoR_1 | 157 | 162 | PF00244 | 0.352 |
LIG_14-3-3_CanoR_1 | 174 | 178 | PF00244 | 0.230 |
LIG_14-3-3_CanoR_1 | 321 | 327 | PF00244 | 0.709 |
LIG_14-3-3_CanoR_1 | 368 | 374 | PF00244 | 0.645 |
LIG_Actin_WH2_2 | 53 | 70 | PF00022 | 0.306 |
LIG_BRCT_BRCA1_1 | 15 | 19 | PF00533 | 0.572 |
LIG_BRCT_BRCA1_1 | 159 | 163 | PF00533 | 0.402 |
LIG_BRCT_BRCA1_1 | 24 | 28 | PF00533 | 0.380 |
LIG_BRCT_BRCA1_1 | 3 | 7 | PF00533 | 0.410 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.523 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.368 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.408 |
LIG_FHA_2 | 191 | 197 | PF00498 | 0.398 |
LIG_FHA_2 | 201 | 207 | PF00498 | 0.463 |
LIG_LIR_Gen_1 | 141 | 149 | PF02991 | 0.557 |
LIG_LIR_Gen_1 | 193 | 202 | PF02991 | 0.242 |
LIG_LIR_Gen_1 | 294 | 303 | PF02991 | 0.499 |
LIG_LIR_Gen_1 | 4 | 15 | PF02991 | 0.466 |
LIG_LIR_Gen_1 | 46 | 57 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 132 | 136 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 141 | 146 | PF02991 | 0.550 |
LIG_LIR_Nem_3 | 154 | 159 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 162 | 167 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 193 | 197 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 232 | 236 | PF02991 | 0.389 |
LIG_LIR_Nem_3 | 294 | 298 | PF02991 | 0.666 |
LIG_LIR_Nem_3 | 4 | 10 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.371 |
LIG_PCNA_PIPBox_1 | 178 | 187 | PF02747 | 0.298 |
LIG_PCNA_yPIPBox_3 | 174 | 185 | PF02747 | 0.295 |
LIG_Pex14_1 | 278 | 282 | PF04695 | 0.300 |
LIG_SH2_CRK | 164 | 168 | PF00017 | 0.323 |
LIG_SH2_CRK | 236 | 240 | PF00017 | 0.454 |
LIG_SH2_CRK | 3 | 7 | PF00017 | 0.484 |
LIG_SH2_CRK | 336 | 340 | PF00017 | 0.686 |
LIG_SH2_CRK | 346 | 350 | PF00017 | 0.703 |
LIG_SH2_CRK | 359 | 363 | PF00017 | 0.589 |
LIG_SH2_GRB2like | 136 | 139 | PF00017 | 0.448 |
LIG_SH2_NCK_1 | 164 | 168 | PF00017 | 0.323 |
LIG_SH2_NCK_1 | 359 | 363 | PF00017 | 0.645 |
LIG_SH2_SRC | 334 | 337 | PF00017 | 0.696 |
LIG_SH2_STAP1 | 104 | 108 | PF00017 | 0.351 |
LIG_SH2_STAP1 | 233 | 237 | PF00017 | 0.376 |
LIG_SH2_STAP1 | 386 | 390 | PF00017 | 0.655 |
LIG_SH2_STAT3 | 386 | 389 | PF00017 | 0.738 |
LIG_SH2_STAT3 | 396 | 399 | PF00017 | 0.603 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 136 | 139 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 164 | 167 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.356 |
LIG_SH2_STAT5 | 279 | 282 | PF00017 | 0.276 |
LIG_SH2_STAT5 | 295 | 298 | PF00017 | 0.518 |
LIG_SH2_STAT5 | 390 | 393 | PF00017 | 0.663 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.384 |
LIG_SH3_2 | 63 | 68 | PF14604 | 0.336 |
LIG_SH3_3 | 57 | 63 | PF00018 | 0.490 |
LIG_SUMO_SIM_par_1 | 111 | 116 | PF11976 | 0.379 |
LIG_SUMO_SIM_par_1 | 78 | 83 | PF11976 | 0.383 |
LIG_TYR_ITIM | 192 | 197 | PF00017 | 0.347 |
LIG_TYR_ITSM | 160 | 167 | PF00017 | 0.309 |
LIG_WRC_WIRS_1 | 181 | 186 | PF05994 | 0.345 |
MOD_CDC14_SPxK_1 | 65 | 68 | PF00782 | 0.331 |
MOD_CDK_SPxK_1 | 62 | 68 | PF00069 | 0.338 |
MOD_CK1_1 | 109 | 115 | PF00069 | 0.356 |
MOD_CK1_1 | 139 | 145 | PF00069 | 0.448 |
MOD_CK1_1 | 151 | 157 | PF00069 | 0.465 |
MOD_CK1_1 | 176 | 182 | PF00069 | 0.417 |
MOD_CK1_1 | 207 | 213 | PF00069 | 0.424 |
MOD_CK1_1 | 361 | 367 | PF00069 | 0.686 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.393 |
MOD_Cter_Amidation | 304 | 307 | PF01082 | 0.380 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.692 |
MOD_GlcNHglycan | 115 | 118 | PF01048 | 0.619 |
MOD_GlcNHglycan | 303 | 306 | PF01048 | 0.350 |
MOD_GlcNHglycan | 322 | 325 | PF01048 | 0.389 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.442 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.409 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.432 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.384 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.259 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.313 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.386 |
MOD_GSK3_1 | 262 | 269 | PF00069 | 0.462 |
MOD_GSK3_1 | 301 | 308 | PF00069 | 0.534 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.368 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.502 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.315 |
MOD_N-GLC_1 | 100 | 105 | PF02516 | 0.570 |
MOD_N-GLC_1 | 134 | 139 | PF02516 | 0.620 |
MOD_N-GLC_1 | 151 | 156 | PF02516 | 0.540 |
MOD_N-GLC_1 | 157 | 162 | PF02516 | 0.516 |
MOD_N-GLC_1 | 266 | 271 | PF02516 | 0.655 |
MOD_N-GLC_1 | 35 | 40 | PF02516 | 0.576 |
MOD_N-GLC_2 | 138 | 140 | PF02516 | 0.647 |
MOD_NEK2_1 | 113 | 118 | PF00069 | 0.410 |
MOD_NEK2_1 | 119 | 124 | PF00069 | 0.372 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.550 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.292 |
MOD_NEK2_1 | 177 | 182 | PF00069 | 0.265 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.426 |
MOD_NEK2_1 | 291 | 296 | PF00069 | 0.457 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.425 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.362 |
MOD_NEK2_2 | 305 | 310 | PF00069 | 0.531 |
MOD_PIKK_1 | 166 | 172 | PF00454 | 0.429 |
MOD_PIKK_1 | 197 | 203 | PF00454 | 0.408 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.403 |
MOD_PKA_2 | 301 | 307 | PF00069 | 0.596 |
MOD_PKA_2 | 320 | 326 | PF00069 | 0.565 |
MOD_PKA_2 | 367 | 373 | PF00069 | 0.682 |
MOD_Plk_1 | 100 | 106 | PF00069 | 0.316 |
MOD_Plk_1 | 151 | 157 | PF00069 | 0.417 |
MOD_Plk_1 | 22 | 28 | PF00069 | 0.448 |
MOD_Plk_1 | 223 | 229 | PF00069 | 0.395 |
MOD_Plk_1 | 35 | 41 | PF00069 | 0.353 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.439 |
MOD_Plk_4 | 159 | 165 | PF00069 | 0.304 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.370 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.409 |
MOD_Plk_4 | 226 | 232 | PF00069 | 0.364 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.318 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.355 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.418 |
MOD_ProDKin_1 | 358 | 364 | PF00069 | 0.733 |
MOD_ProDKin_1 | 62 | 68 | PF00069 | 0.457 |
TRG_ENDOCYTIC_2 | 164 | 167 | PF00928 | 0.317 |
TRG_ENDOCYTIC_2 | 194 | 197 | PF00928 | 0.354 |
TRG_ENDOCYTIC_2 | 236 | 239 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 279 | 282 | PF00928 | 0.280 |
TRG_ENDOCYTIC_2 | 295 | 298 | PF00928 | 0.535 |
TRG_ENDOCYTIC_2 | 3 | 6 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 346 | 349 | PF00928 | 0.690 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0L6 | Leptomonas seymouri | 46% | 95% |
A0A3R7P473 | Trypanosoma rangeli | 30% | 100% |
A4HD64 | Leishmania braziliensis | 62% | 99% |
A4I0M9 | Leishmania infantum | 99% | 100% |
D0A6X7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 100% |
E9AWJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4QAX4 | Leishmania major | 90% | 100% |
V5C0T3 | Trypanosoma cruzi | 27% | 100% |